Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin F Sprinzl

Showing results (11-20 of 41) with videos related to

Pageof 5
Sort By:
Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research|July 10, 2020
Clinical Frailty Scale for risk stratification in patients with SARS-CoV-2 infectionChristian Labenz, Wolfgang M Kremer, Jörn M Schattenberg, et al.
Peerj|September 25, 2023
Evidence for the utility of cfDNA plasma concentrations to predict disease severity in COVID-19: a retrospective pilot studyKatharina Hoeter, Elmo Neuberger, Susanne Fischer, et al.
Journal of Cachexia, Sarcopenia and Muscle|December 9, 2021
Sonographic assessment of low muscle quantity identifies mortality risk during COVID-19: a prospective single-centre studyWolfgang M Kremer, Christian Labenz, Robert Kuchen, et al.
Clinical and Translational Gastroenterology|August 9, 2020
Validation of the Clinical Frailty Scale for the Prediction of Mortality in Patients With Liver CirrhosisWolfgang M Kremer, Michael Nagel, Michael Reuter, et al.
Infection|July 10, 2026
Topical trichloroacetic acid versus electrocautery for treatment of anal intraepithelial neoplasia in people living with HIV: a multicentre, randomised, non-inferiority trial (TECAIN-study)Stefan Esser, Alexander Kreuter, Anja Potthoff, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|November 7, 2012
Metabolic syndrome and its association with fatty liver disease after orthotopic liver transplantationMartin F Sprinzl, Arndt Weinmann, Nikola Lohse, et al.
International Journal of Cardiology|August 6, 2018
Interferon- and ribavirin-free therapy with new direct acting antivirals (DAA) for chronic hepatitis C improves vascular endothelial functionFrank P Schmidt, Tim Zimmermann, Till Wenz, et al.
Medical Microbiology and Immunology|April 15, 2021
Evaluation of a laboratory-based high-throughput SARS-CoV-2 antigen assay for non-COVID-19 patient screening at hospital admissionFriederike Häuser, Martin F Sprinzl, Kim J Dreis, et al.
BMC Gastroenterology|August 5, 2015
Early virological response may predict treatment response in sofosbuvir-based combination therapy of chronic hepatitis c in a multi-center "real-life" cohortNiels Steinebrunner, Martin F Sprinzl, Tim Zimmermann, et al.
Journal of Clinical Gastroenterology|November 16, 2018
Clinical Predictors for Poor Quality of Life in Patients With Covert Hepatic EncephalopathyChristian Labenz, Gerrit Toenges, Jörn M Schattenberg, et al.
Pageof 5

Showing results (11-20 of 41) with videos related to

Sort By:
Pageof 5
Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research|July 10, 2020
Clinical Frailty Scale for risk stratification in patients with SARS-CoV-2 infectionChristian Labenz, Wolfgang M Kremer, Jörn M Schattenberg, et al.
Peerj|September 25, 2023
Evidence for the utility of cfDNA plasma concentrations to predict disease severity in COVID-19: a retrospective pilot studyKatharina Hoeter, Elmo Neuberger, Susanne Fischer, et al.
Journal of Cachexia, Sarcopenia and Muscle|December 9, 2021
Sonographic assessment of low muscle quantity identifies mortality risk during COVID-19: a prospective single-centre studyWolfgang M Kremer, Christian Labenz, Robert Kuchen, et al.
Clinical and Translational Gastroenterology|August 9, 2020
Validation of the Clinical Frailty Scale for the Prediction of Mortality in Patients With Liver CirrhosisWolfgang M Kremer, Michael Nagel, Michael Reuter, et al.
Infection|July 10, 2026
Topical trichloroacetic acid versus electrocautery for treatment of anal intraepithelial neoplasia in people living with HIV: a multicentre, randomised, non-inferiority trial (TECAIN-study)Stefan Esser, Alexander Kreuter, Anja Potthoff, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|November 7, 2012
Metabolic syndrome and its association with fatty liver disease after orthotopic liver transplantationMartin F Sprinzl, Arndt Weinmann, Nikola Lohse, et al.
International Journal of Cardiology|August 6, 2018
Interferon- and ribavirin-free therapy with new direct acting antivirals (DAA) for chronic hepatitis C improves vascular endothelial functionFrank P Schmidt, Tim Zimmermann, Till Wenz, et al.
Medical Microbiology and Immunology|April 15, 2021
Evaluation of a laboratory-based high-throughput SARS-CoV-2 antigen assay for non-COVID-19 patient screening at hospital admissionFriederike Häuser, Martin F Sprinzl, Kim J Dreis, et al.
BMC Gastroenterology|August 5, 2015
Early virological response may predict treatment response in sofosbuvir-based combination therapy of chronic hepatitis c in a multi-center "real-life" cohortNiels Steinebrunner, Martin F Sprinzl, Tim Zimmermann, et al.
Journal of Clinical Gastroenterology|November 16, 2018
Clinical Predictors for Poor Quality of Life in Patients With Covert Hepatic EncephalopathyChristian Labenz, Gerrit Toenges, Jörn M Schattenberg, et al.
Pageof 5